PatriciaJ.SulakMD

PubMed

• 29 citations
  Extended Cycle Combined Oral Contraceptives and Prophylactic Frovatriptan During the Hormone-Free Interval in Women with Menstrual-Related Migraines
  Andrea Coffee, Patricia J. Sulak, Alexandria J Hill, Darci J Hansen, Thomas J. Kuehl, Jeffrey W. Clark> ;Journal of Women's Health. 2014 Apr 7
• 16 citations
  Attitudes and prescribing patterns of extended-cycle oral contraceptives.
  Divya L. Seval, Terry Buckley, Thomas J. Kuehl, Patricia J. Sulak> ;Contraception. 2011 Jul 1
• 48 citations
  Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial.
  Patricia J. Sulak, Virginia J. Smith, Andrea Coffee, Iris Witt, Alicia L. Kuehl, Thomas J. Kuehl> ;Obstetrics and Gynecology. 2008 Sep 1
• 3 citations
  New forms of contraception.
  Kristen Plastino, Patricia J. Sulak> ;Obstetrics and Gynecology Clinics of North America. 2008 Jun 1
• 5 citations
  Comparison of Scales for Evaluating Premenstrual Symptoms in Women Using Oral Contraceptives
  Andrea L. Coffee, Thomas J. Kuehl, Patricia J. Sulak> ;Pharmacotherapy. 2008 May 1
• 5 citations
  Pituitary-ovarian hormone levels and symptoms in oral contraceptive users: comparison of a 21/7-day and extended regimen.
  Thomas J. Kuehl, A Michael Speikermann, Sherilyn Willis, Andrea Coffee, Patricia J. Sulak> ;The Journal of Reproductive Medicine. 2008 Apr 1
• 29 citations
  Continuous oral contraception: Changing times.
  Patricia J. Sulak> ;Best Practice & Research. Clinical Obstetrics & Gynaecology. 2008 Apr 1
• 52 citations
  Evaluation of pituitary–ovarian axis suppression with three oral contraceptive regimens
  Misty A. Vandever, Thomas J. Kuehl, Patricia J. Sulak, Iris Witt, Andrea L. Coffee, Thomas J. Wincek, Kathleen Z. Reape> ;Contraception. 2008 Mar 1
• Toward optimal health: advances in contraceptive options. Interview by Jodi R. Godfrey.
  Sulak, P.J.> ;J Womens Health (Larchmt). 2008-01-01
• 68 citations
  Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen.
  Andrea L. Coffee, Patricia J. Sulak, Thomas J. Kuehl> ;Contraception. 2007 Jun 1
• 112 citations
  Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval.
  Patricia J. Sulak, Sherilyn Willis, Thomas J. Kuehl, Andrea Coffee, Jeffrey W. Clark> ;Headache. 2007 Jan 1
• 77 citations
  Oral contraceptives and premenstrual symptoms : Comparison of a 21/7 and extended regimen
  Andrea L. Coffee, Thomas J. Kuehl, Sherilyn Willis, Patricia J. Sulak> ;American Journal of Obstetrics and Gynecology. 2006 Nov 1
• 73 citations
  Greater inhibition of the pituitary--ovarian axis in oral contraceptive regimens with a shortened hormone-free interval.
  Sherilyn Willis, Thomas J. Kuehl, A. Michael Spiekerman, Patricia J. Sulak> ;Contraception. 2006 Aug 1
• 15 citations
  Impact of an adolescent sex education program that was implemented by an academic medical center.
  Patricia J. Sulak, Sara J. Herbelin, Dee Dee A. Fix, Thomas J. Kuehl> ;American Journal of Obstetrics and Gynecology. 2006 Jul 1
• 48 citations
  Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen.
  Patricia J. Sulak, Thomas J. Kuehl, Andrea L. Coffee, Sherilyn Willis> ;American Journal of Obstetrics and Gynecology. 2006 Oct 1
• 27 citations
  Attitudes and prescribing preferences of health care professionals in the United States regarding use of extended-cycle oral contraceptives.
  Patricia J. Sulak, Terry Buckley, Thomas J. Kuehl> ;Contraception. 2006 Jan 1
• 31 citations
  The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days
  Jean-Michel Foidart, Patricia J. Sulak, Ilka Schellschmidt, Doris Zimmermann> ;Contraception. 2006 Jan 1
• 5 citations
  Analysis of knowledge and attitudes of adult groups before and after attending an educational presentation regarding adolescent sexual activity.
  Patricia J. Sulak, Sara J. Herbelin, Alicia L. Kuehl, Thomas J. Kuehl> ;American Journal of Obstetrics and Gynecology. 2005 Dec 1
• 12 citations
  Ovulation suppression of premenstrual symptoms using oral contraceptives
  Patricia J. Sulak> ;The American Journal of Managed Care. 2005 Dec 1
• 45 citations
  Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding
  Patricia J. Sulak, Jenny Carl, Isai Gopalakrishnan, Andrea L. Coffee, Thomas J. Kuehl> ;Contraception. 2004 Oct 1
• 2 citations
  Contraceptive redesign: new progestins/new regimens.
  Patricia J. Sulak> ;The Journal of Family Practice. 2004 Sep 1
• 87 citations
  Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone
  Gloria Bachmann, Patricia J. Sulak, Carole Sampson-Landers, Norbert Benda, Joachim Marr> ;Contraception. 2004 Sep 1
• 3 citations
  Oral contraceptive update: new agents and regimens.
  Patricia J. Sulak> ;The Journal of Family Practice. 2004 Jul 1
• 2 citations
  Adolescent sexual health.
  Patricia J. Sulak> ;The Journal of Family Practice. 2004 Jul 1
• 1 citations
  Sexually transmitted diseases
  Patricia J. Sulak> ;Seminars in Reproductive Medicine. 2003 Nov 1
• Join now to see all

Journal Articles

• Wellness: Stifle Stress and Sever Suffering.  
  Sulak, PJ, The Female Patient Vol 3, p17-19
• Wellness: Know the Normal Numbers-and Yours!  
  Sulak, PJ, The Female Patient Vol 37, p17-20
• Wellness: Critique Your Calorie Consumption.  
  Sulak PJ, The Female Patient Vol 36, p.14-19
• Wellness: Make Movement Mandatory.  
  Sulak, PJ, The Female Patient Vol 36, p.45-47
• Wellness: Habits That Lead to Health and Happiness.  
  Sulak PJ, The Female Patient Vol 36, p. 11-12
• Teens and SEX: $$$$$$$.  
  Sulak PJ, The Female Patient, Vol 36, p. 1-2
• Prescribing Patterns of Extended Oral Contraceptive Regimens.  
  Seval, Divya MSIV, Sulak P, Buckley T, Kuehl, T, Contraception 84, p. 71-75
• Management of Ovulatory Heavy Menstrual Bleeding.  
  Fothergill R, Sulak P, The Female Patient Vol 35, p.15-19.
• Healthcare Crisis: Another Bailout.  
  Sulak PJ, The Female Patient, Vol 34, p.1-2
• The Redesign of Contraception: The Demise of 21/7 Regimens.  
  Sulak, PJ, Haney C, Nakajima S, Acog Update Volume 34 Number 10
• Adolescent Sexual Health: The Critical Role of Healthcare Professionals.  
  Sulak, PJ, Plastino KA, Davis AJ, Acog Update Volume 34 Number 6
• Alteration of the hormone free internal during oral contraception.  
  Sulak PJ, Liu JH, Supplement to Sexuality, Reproduction, and Menopause
• The frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring.  
  Sulak PJ, Smith V, Coffee A, Witt I, Kuehl T, Kuehl A, Obstet Gynecol 2008; 112: 563-71
• Alteration of the hormone free interval in oral contraception.  
  Sulak PJ, Lui HL, Podcast and publication
• Comparison of Symptom Scales for Premenstrual Symptoms in Oral Contraceptive Users.  
  Coffee A, Sulak P, Kuehl T, Pharmacotherapy 2008; 28(5): 576-83
• Continuous Hormonal Contraception: An Increasingly Popular Option.  
  Sulak, P, The Female Patient 2008; 33: 20-29
• Continuous Oral Contraception: Changing Times. Best Practices in Research.  
  Sulak PJ, Clinical Obstetrics and Gynaecology 2008; Apr 22 (2): 255-74
• Toward Optimal Health: Advances in Contraceptive Options.  
  Sulak PJ, Journal of Women’s Health 2008; 17(1):11-14
• Teens and Sex: What’s the Message?  
  Sulak P, The Female Patient Vol. 32, p. 11-1
• Is there a Place in Today’s Armamentarium for 21/7 Oral Contraceptives.  
  Sulak P, Female Patient
• Longterm assessment of symptomatology and satisfaction of an extended oral contraceptive regimen.  
  Coffee A, Sulak P, Kuehl T, Contraception 2007; 75: 444-9
• Advantage of new pill regimens: The demise of 21/7.  
  Sulak P, Gynecology Forum 2007; 12 (1): 7-10
• Is Menstruation Necessary?  
  Sulak PJ, The Female Patient,31(11): 43-44
• Elimination and alteration of the hormone-free interval: Reasons and methods.  
  Sulak PJ, The Female Patient
• The impact of the Women’s Health Initiative on management of the perimenopausal patient.  
  Sulak PJ, The Female Patient Vol 31
• Join now to see all

Books/Book Chapters

• Atlas of Clinical Gynecology. 
  Chapter: Dysfunctional Uterine Bleeding: Evaluation and Treatment 
  Sulak PJ, Yandell PMEditors: Stenchever MA, Mishell.
• PERIMENOPAUSE 
  Chapter: Contraceptive Needs and Options in Perimenopausal Women 
  Page 281 - 286Sulak PJEditors: Lobo R.New York
• PerimenopaulsaL Gynecology. 
  Chapter: Creative use of oral contraceptives in the perimenopausal patient 
  Sulak PJParthenon Publishing, NY
• Telindes Operative Gynecology. 
  Chapter: Non-Surgical Correction of Pelvic Support Defects: Use of Vaginal Support Devices (Chapter 38) 
  Sulak PJEditors: John A. Rock and John D.Edition 8,
• Join now to see all

Abstracts/Posters

• Evaluation of the pituitary-ovarian axis suppression with three different oral contraceptive regimens.
  Sulak P, Kuehl T, Coffee A, Vandever M, Reape K, The ACOG ACM, San Diego, CA
• Current Clinical Issues in Oral Contraceptives.
  Sulak PJ, Contemporary Ob/Gyn, 1996; 41(12)(Supp
• Greater Inhibition of the Pituitary Ovarian Axis with a Shortened Hormone Free Interval.
  Willis S, Sulak P, Kuehl T, The Annual ASRM meeting, Philadelphia PA
• Comparison of a 21 / 7 Day Oral Contraceptives Containing 19-Nortestosterone Progestins with a Drospirenone Containing OC.
  Willis S, Sulak P, Kuehl T, The 17th Annual Resident Research Day / Bunkley Day, Scott & White Hospital, Temple Texas
• Efficacy and Safety of a Twenty-Four Day Oral Contraceptive Regimen With Ethinylestradiol (20mcg) and Drospirenone (3mg).
  Bachmann G, Sulak P, Marr J, The ACOG Annual Clinical Meeting, Philadelphia PA
• Analysis of Knowledge and Attitudes of Adult Groups Regarding Adolescent Sexual Health Before and After a Scott and White Worth The Wait Program.
  Sulak P, Kuehl A, Todaro D, Fix D, Kuehl T, Annual Meeting of the Medical Institute, Washington D.C
• Join now to see all

Lectures

• Serum Hormone Levels, Bleeding Patterns, and Symptomatology in a 21/7 Versus Extended Regimen of a Drospirenone Containing Oral Contraceptive. 
  Presented at the 12th Annual Controversies in Gynecology, Venice Italy
• OCs: therapeutic uses and quality of life benefits. The Science of OCs and Todays Clinical Challenges. 
  Scientific Symposium at the American Society for Reproductive Medicine 54th Annual Meeting